USA
Compliance
Consultant
October 2016
Vol.10, No. 37, Autumn 2016
Fabiana Lacerca-Allen
More
M. Fabiana Lacerca-Allen has had more than 20 years of experience working for leading
American companies such as Elan, Mylan, Bristol-Myers Squibb Company, Microsoft, Merck
and AT&T. She has counseled and litigated in the field of international business transactions
and international environment law. She has extensive experience in the pharmaceutical
industry in leadership roles in charge of legal and compliance teams. She has counseled
and represented clients in a broad range of questions, including strategic business initiatives
ensuring compliance with laws and regulations, and corporate policy. Ms. Lacerca-Allen
has provided legal support and strategic advice on opportunities and trends in law
particularly within the government sector as well as with major and strategic corporate
accounts. Fabiana has established policies and oversight on key areas of compliance
affecting internationals markets and she has been able to positively impact the perception
of compliance creating compliance training programs and relevant standard operating
procedures and has been involved in validating and aiding due diligence in the
compliance industry.
frequently requested as
speaker and participant in forum. Recognized in the industry by Hispanic Executive
Magazine in 2013, http://hispanicexecutive.com/2013/fabiana-lacerca-allen/;
a
theguardian, recognized as 2015 Women in Leadership, Inspiring Leaders:
http://www.theguardian.com/women-in-leadership/2015/may/12/know-who-you-want-to
be-kidnapped-with-and-four-more-tips-for-leaders; served as Chair to the Bay Area Ethics
& Compliance Association (BECA); and, served as Co Chair for CBI, an Advanstar
company serving the Life Sciences industry.
Ms. Lacerca-Allen was invited to join the Gioja Research Institute while she was a student
researching on environmental law. She was recipient of 1992 UCLA’s tuition waiver based
on merit and recognition, and she represented UCLA in the Roscoe Foundation National
Essay Contest submitting a paper on Global Warming.
Ethiprax
More
Elan Drug Technologies (EDT) is the world’s leading drug delivery company and is a business unit of Elan (NYSE:ELN). As a fully integrated drug delivery business, we deliver clinically meaningful benefits to patients, by using our extensive experience and proprietary delivery technologies in partnership with pharmaceutical companies to develop new and innovative products.
USA
Compliance
Consultant
October 2016
Vol.10, No. 37, Autumn 2016